
Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients ...
Introduction Osteosarcoma (OS) is the most prevalent primary malignant tumor of the bone. It primarily affects children and adolescents, with an additional peak in incidence observed in adults over the age of 50.1 The current treatment regimen for …